0001493152-20-019736.txt : 20201021
0001493152-20-019736.hdr.sgml : 20201021
20201021160533
ACCESSION NUMBER: 0001493152-20-019736
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190913
FILED AS OF DATE: 20201021
DATE AS OF CHANGE: 20201021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jenusaitis Matthew
CENTRAL INDEX KEY: 0001357864
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38325
FILM NUMBER: 201250618
MAIL ADDRESS:
STREET 1: 2 GOODYEAR
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hancock Jaffe Laboratories, Inc.
CENTRAL INDEX KEY: 0001661053
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330936180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-261-2900
MAIL ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
ownership.xml
X0306
4
2019-09-13
0
0001661053
Hancock Jaffe Laboratories, Inc.
HJLI
0001357864
Jenusaitis Matthew
C/O HANCOCK JAFFE LABORATORIES, INC.
70 DOPPLER
IRVINE
CA
92618
1
0
0
0
Common Stock
2020-07-18
4
A
0
62500
0
A
62500
D
Restricted Stock Units
2019-09-13
4
A
0
78125
0
A
Common Stock
78125
78125
D
Stock Option (Right to Buy)
2.00
2019-09-13
4
A
0
60000
0
A
2029-09-13
Common Stock
60000
60000
D
Stock Option (Right to Buy)
0.40
2020-07-18
4
A
0
100000
0
A
2030-07-18
Common Stock
100000
100000
D
Upon vesting, each Restricted Stock Unit ("RSU") entitles the Reporting Person to one share of the Issuer's common stock or the cash equivalent, at the discretion of the Issuer.
The RSU were issued to the Reporting Person on September 13, 2019 in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the "Plan"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) September 13, 2020; (ii) September 13, 2021; and (iii) September 13, 2022.
The common stock options were issued to the Reporting Person on September 13, 2019 in connection with joining the Issuer's board of directors pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from September 13, 2019.
The common stock options were issued to the Reporting Person pursuant to the Plan on July 18, 2020 as part of the annual board compensation package for 2020. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the 2020 calendar year.
/s/ Matthew Jenusaitis
2020-10-21